PharmiWeb

Positive Phase 3 Data Demonstrate Potential for ENTYVIO® (vedolizumab) to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Co…

Pivotal Phase 3 global KEPLER study of vedolizumab intravenous (IV) in pediatric patients ages 2 to 17, who had an inadequate ...
IEEE

Multi-Objective Optimization of a 1P7S LFP Prismatic Battery Pack With Phase Change Material as a Battery Thermal Management System in High-Power Applications

Abstract: Battery Thermal Management Systems (BTMS) are crucial for regulating the temperature of lithium-ion battery packs, particularly in high-power applications such as electric vehicles. This ...